Royalty Pharma plc (RPRX)
$58.99+4.28%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $25.4B
- Beta
- 0.41
- Div yield
- 1.57%
- P/E (TTM)
- 24.47
- Short % float
- 3.12%
- Days to cover
- 4.4
- SI change
- +10.6%
- 1W
- +3.93%
- 1M
- +0.89%
- vs SPY 1W
- +4.91%
- vs SPY 1M
- -0.98%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RPRX?
- LOPJLB’s latest quantitative signal on Royalty Pharma plc (RPRX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is RPRX in?
- Royalty Pharma plc (RPRX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Royalty Pharma plc (RPRX) do?
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and dia…